Division of General Internal Medicine and Public Health Archive — Page 4 of 7
-
November 17, 2020
Statins to be studied for prevention of dementia, disability and heart disease
Vanderbilt University Medical Center researchers are enrolling adults aged 75 and over to study whether taking atorvastatin, a drug commonly used to lower cholesterol also called Lipitor®, can help maintain health by preventing dementia, disability, and heart disease. -
September 10, 2020
Roumie to direct Master of Public Health program
Christianne Roumie, MD, MPH, has been named director of the Vanderbilt University School of Medicine Master of Public Health program, a two-year interdisciplinary program accredited by the Council on Education for Public Health. -
April 2, 2020
Study aims to shield health workers from COVID-19 infection
VUMC is playing a key role in a national effort to establish a registry of U.S. health care workers and test whether the anti-malarial drug hydroxychloroquine (HCQ) will protect them, their patients and their families from COVID-19. -
October 3, 2019
Diabetes drug study explores cardiovascular risks for patients with kidney disease
An observational study using medical record information from nearly 50,000 U.S. military veterans sheds new light on which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease. -
September 12, 2019
Study shows benefit of palliative care for liver disease patients
A Vanderbilt study sheds new light on the impact of palliative care. -
August 20, 2019
Quitting smoking associated with lower risk of cardiovascular disease
A new Vanderbilt study documents the great incentive for current smokers to quit. -
July 25, 2019
Summit highlights clinical improvement successes
A summit at Vanderbilt reviewed achievements of an ongoing regional effort to transform clinical practices in ways that would improve the quality of patient care, reduce costs and improve health outcomes